跳至主要内容
临床试验/NCT05035771
NCT05035771招募中不适用

A Safety and Feasibility Study of Intraprocedural Physiology Measurements During Peripheral Endovascular Treatment

Mid and South Essex NHS Foundation Trust2 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2023年3月18日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
20
试验地点
2
主要终点
Pressure wire measurements

研究概览

简要总结

Defining the role of intraprocedural physiology measurements in peripheral endovascular treatment

详细描述

Endovascular treatment for peripheral arterial disease is commonly performed for claudication or critical limb threatening ischaemia (ischaemic rest pain, foot ulcer or gangrene). Disease is generally identified using Ankle Brachial Pressure Index or Toe Brachial Pressure Index and then lesions delineated using Doppler ultrasound or CT angiography. Clinical severity is staged using absolute walking distance (metres) in claudicants or the Society for Vascular Surgery wIfI (wound, ischaemia, foot infection) score in critical limb threatening ischaemia patients.

Intra-procedural lesion assessment and quality control is currently performed anatomically using angiography alone, with a few centres using pullback pressures across a lesion to give supplementary trans-lesional gradients or intravascular ultrasound (IVUS) to give pre and post intervention diameter and vessel area measurements. No direct or quantitative assessment of flow, or pressure normalisation across lesions is currently performed during interventions to improve blood flow to the leg.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18 years of age
  • Peripheral arterial stenosis scheduled for endovascular treatment

排除标准

  • < 18 year of age
  • Unable to give informed consent
  • Estimated GFR ≤30 mL/min
  • Dialysis dependent
  • Unable to receive antiplatelets or periprocedural anticoagulation
  • Pregnancy or breastfeeding
  • Contraindication to adenosine (severe asthma or COPD)
  • WIfI ulcer score <2 (no exposed bone)
  • WIfI infection score <2 (skin and subcutaneous tissues only)
  • WIfI gangrene score <3 (limited to digits)
  • COVID-19 positive
  • NYHA IV heart failure
  • Contra-indication to adenosine including arrhythmia, asthma or allergy

结局指标

主要结局

Pressure wire measurements

时间窗: 12 months

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验